This site is intended for healthcare professionals only
LoginRegister
Alkem Binding Offer to Acquire Stake in OcclutechAlkem Arm Makes Binding Offer to Acquire 51-55% Stake in Swiss Medtech Firm Occlutech
Aurobindo Pharma’s Subsidiary gets US FDA nod for ADQUEY OintmentAurobindo Arm Acrotech Secures USFDA Nod for Atopic Dermatitis Drug ADQUEY
Alkems Enzene Unit Gets 6 USFDA ObservationsAlkem's Enzene Unit Gets 6 USFDA Observations
Zydus Secures Final USFDA Approval for Ammonium Lactate Cream, Expands Generics BasketZydus Secures Final USFDA Approval for Ammonium Lactate Cream, Expands Generics Basket
Delhi Drug Control Dept Raids 12 Firms in Nangloi, 10 Found Violating Rules, 49 Samples LiftedDelhi Drug Control Dept Raids 12 Firms in Nangloi, 10 Found Violating Rules, 49 Samples Lifted
Jubilant Pharmovas Canada Plant Gets USFDA OAI Status, Remediation UnderwayJubilant Pharmova's Canada Plant Gets USFDA OAI Status, Remediation Underway
GTE exception list of medical deviceDoP Issues Draft Revised List of 354 Medical Devices Exempt from Global Procurement, Invites...
All Cancer Drugs Regulated Under DPCO, 131 Formulations Price-Capped: GovtAll Cancer Drugs Regulated Under DPCO, 131 Formulations Price-Capped: Govt
Shilpa Medicare Partners NXI Therapeutics for Autoimmune Therapy Development, ManufacturingShilpa Medicare Partners NXI Therapeutics for Autoimmune Therapy Development, Manufacturing
47 Drug Inspectors for 2.5 Lakh Batches: Kerala Faces Oversight Strain47 Drug Inspectors for 2.5 Lakh Batches: Kerala Faces Oversight Strain
Pharmacy Trader Loses Rs 6.7 Crore to Fake Investment App FraudPharmacy Trader Loses Rs 6.7 Crore to Fake Investment App Fraud
Lupin Gets Zero USFDA Observations for Nagpur PlantLupin Gets Zero USFDA Observations for Nagpur Plant
X